Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 16, 2024

SELL
$209.01 - $232.56 $14,839 - $16,511
-71 Reduced 85.54%
12 $3,000
Q3 2022

Oct 27, 2022

SELL
$204.81 - $262.19 $3,686 - $4,719
-18 Reduced 17.82%
83 $17,000
Q2 2022

Jul 12, 2022

BUY
$213.86 - $277.87 $1,283 - $1,667
6 Added 6.32%
101 $24,000
Q1 2022

Apr 27, 2022

SELL
$259.82 - $298.18 $1,299 - $1,490
-5 Reduced 5.0%
95 $25,000
Q3 2021

Nov 02, 2021

BUY
$274.82 - $308.34 $2,473 - $2,775
9 Added 9.89%
100 $28,000
Q2 2021

Aug 05, 2021

BUY
$251.87 - $278.14 $1,007 - $1,112
4 Added 4.6%
91 $25,000
Q1 2021

Apr 26, 2021

SELL
$204.88 - $255.03 $6,965 - $8,671
-34 Reduced 28.1%
87 $22,000
Q4 2020

Feb 03, 2021

BUY
$186.91 - $214.42 $9,345 - $10,721
50 Added 70.42%
121 $25,000
Q2 2020

Jul 21, 2020

BUY
$113.31 - $182.44 $8,045 - $12,953
71 New
71 $12,000

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $21.3B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Financial Management Professionals, Inc. Portfolio

Follow Financial Management Professionals, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Management Professionals, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Management Professionals, Inc. with notifications on news.